HSP90B1 and polycystic ovary syndrome: Curiously, the in vivo treatment with AGE-albumin did not alter GRP94; however, in lead- and polycystic ovary syndrome-induced UPR, the GRP78 increase was reported to be more significant than the GRP94 increase40,41.